Sign In
Buy BCS
Barclays Earnings Calls
| Release date | Apr 28, 2026 |
| EPS estimate | $0.750 |
| EPS actual | $0.760 |
| EPS Surprise | 1.33% |
| Revenue estimate | 10.876B |
| Revenue actual | 11.017B |
| Revenue Surprise | 1.30% |
| Release date | Feb 10, 2026 |
| EPS estimate | $0.420 |
| EPS actual | $0.460 |
| EPS Surprise | 9.52% |
| Revenue estimate | 9.416B |
| Revenue actual | 9.677B |
| Revenue Surprise | 2.78% |
| Release date | Oct 22, 2025 |
| EPS estimate | $0.540 |
| EPS actual | $0.560 |
| EPS Surprise | 3.70% |
| Revenue estimate | 9.261B |
| Revenue actual | 9.643B |
| Revenue Surprise | 4.13% |
| Release date | Jul 29, 2025 |
| EPS estimate | $0.500 |
| EPS actual | $0.620 |
| EPS Surprise | 24.00% |
| Revenue estimate | 9.375B |
| Revenue actual | 25.114B |
| Revenue Surprise | 167.87% |
Last 4 Quarters for Barclays
Below you can see how BCS performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Jul 29, 2025 |
| Price on release | $20.05 |
| EPS estimate | $0.500 |
| EPS actual | $0.620 |
| EPS surprise | 24.00% |
| Date | Price |
|---|---|
| Jul 23, 2025 | $19.46 |
| Jul 24, 2025 | $19.40 |
| Jul 25, 2025 | $19.62 |
| Jul 28, 2025 | $19.41 |
| Jul 29, 2025 | $20.05 |
| Jul 30, 2025 | $19.86 |
| Jul 31, 2025 | $19.62 |
| Aug 01, 2025 | $19.10 |
| Aug 04, 2025 | $19.32 |
| 4 days before | 3.03% |
| 4 days after | -3.64% |
| On release day | -0.95% |
| Change in period | -0.719% |
| Release date | Oct 22, 2025 |
| Price on release | $20.35 |
| EPS estimate | $0.540 |
| EPS actual | $0.560 |
| EPS surprise | 3.70% |
| Date | Price |
|---|---|
| Oct 16, 2025 | $19.95 |
| Oct 17, 2025 | $19.36 |
| Oct 20, 2025 | $19.62 |
| Oct 21, 2025 | $19.49 |
| Oct 22, 2025 | $20.35 |
| Oct 23, 2025 | $20.61 |
| Oct 24, 2025 | $20.68 |
| Oct 27, 2025 | $21.27 |
| Oct 28, 2025 | $21.57 |
| 4 days before | 2.01% |
| 4 days after | 6.00% |
| On release day | 1.28% |
| Change in period | 8.12% |
| Release date | Feb 10, 2026 |
| Price on release | $26.16 |
| EPS estimate | $0.420 |
| EPS actual | $0.460 |
| EPS surprise | 9.52% |
| Date | Price |
|---|---|
| Feb 04, 2026 | $26.52 |
| Feb 05, 2026 | $25.48 |
| Feb 06, 2026 | $26.41 |
| Feb 09, 2026 | $26.71 |
| Feb 10, 2026 | $26.16 |
| Feb 11, 2026 | $26.16 |
| Feb 12, 2026 | $25.54 |
| Feb 13, 2026 | $25.31 |
| Feb 17, 2026 | $25.96 |
| 4 days before | -1.36% |
| 4 days after | -0.765% |
| On release day | 0% |
| Change in period | -2.11% |
| Release date | Apr 28, 2026 |
| Price on release | $23.00 |
| EPS estimate | $0.750 |
| EPS actual | $0.760 |
| EPS surprise | 1.33% |
| Date | Price |
|---|---|
| Apr 22, 2026 | $23.32 |
| Apr 23, 2026 | $22.77 |
| Apr 24, 2026 | $22.95 |
| Apr 27, 2026 | $23.09 |
| Apr 28, 2026 | $23.00 |
| Apr 29, 2026 | $23.00 |
| Apr 30, 2026 | $23.41 |
| May 01, 2026 | $23.43 |
| May 04, 2026 | $22.85 |
| 4 days before | -1.37% |
| 4 days after | -0.652% |
| On release day | 0% |
| Change in period | -2.02% |
Barclays Earnings Call Transcript Summary of Q1 2026
Barclays reported solid Q1 2026 execution across its businesses, driven by structural improvements implemented since 2024. Group RoTE was 13.5% for the quarter, income rose 6% to £8.2bn, and the cost-to-income ratio improved to 56%. The Investment Bank showed improved activity and RWAs were increased modestly to support cyclical opportunities; Barclays announced a £500m buyback as part of its plan to return at least £15bn to shareholders by 2028. Net interest income (NII) momentum continued (group NII guidance for 2026 remains >£13.5bn), helped by stronger deposit behavior and a larger structural hedge (now £18.3bn of gross hedge income locked for 2026–28). Impairments rose to £823m (74bps loan loss rate) and included a £228m single-name charge in securitized products tied to a sophisticated fraud; as a result the firm is constraining lending to certain structured finance counterparties and reducing exposure to highly leveraged non-investment-grade corporates. U.K. lending grew 5% y/y and the U.K. businesses, the U.S. Consumer Bank and the Investment Bank all delivered double-digit RoTEs. Management reiterated targets for 2026 and 2028 (RoTE >12% in 2026 and >14% in 2028) and emphasized balance sheet resilience (CET1 14.1%, LCR 165%, NSFR 135%). Key operational items: ~£150m of gross efficiency savings toward a £2bn target; migration of corporate clients onto a single iPortal platform; launch of Premier Wealth Management in the Barclays U.K. app in Q2. Management flagged vigilance around macro and inflationary risks (Middle East developments, energy price impact), but noted no current signs of credit weakness across U.K. or U.S. consumer and corporate lending.
